coptisine has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Ding, K; Ding, Y; Hua, S; Huang, Y; Jiang, J; Li, M; Li, P; Ma, Y; Qiao, D; Yang, X; Yin, H; Yue, Q; Zeng, L; Zhao, M | 1 |
| Chen, J; Huang, Z; Li, C; Li, Y; Liang, Y; Liu, J; Luo, C; Ni, C; Su, Z; Wang, Y; Xie, J | 1 |
2 other study(ies) available for coptisine and Colitis
| Article | Year |
|---|---|
N6-methyladenosine modification of TSC1 mRNA contributes to macrophage polarization regulated by Coptisine in DSS-induced ulcerative colitis.
Topics: Animals; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; RNA, Messenger; Tuberous Sclerosis | 2024 |
Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Apoptosis Regulatory Proteins; Berberine; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation Mediators; Intestinal Mucosa; Male; Mice, Inbred C57BL; Permeability; Tight Junction Proteins; Tight Junctions | 2021 |